What move does the options market price into Nektar Therapeutics's report?

Implied ±11.8%, either direction.

NKTRNasdaqPharmaceutical Preparations

Nektar Therapeutics (NKTR) earnings date, market-implied expected move, and options open interest by expiry

39.23

+2.28 · +6.18%

post 37.69 −3.93%

After hours15:59 ETdelayed

Open36.80Volume823,213Mkt cap$1.3BEPS-4.75

Day36.80 – 38.2462%52-wk33.40 – 109.006%

NKTR

Nektar Therapeutics

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±11.8%implied · straddle

33.3242.20

spot 37.76exp Nov 20ATM strike 38ATM straddle 5.22IV 80%

Nov 3 close

Expected move

Inputs

Next report

Nov 12

after close · in 9 days

confirmedQ3 FY26

Calendar

Next report

Last report

−3.82%

vs ±5.8% implied · ×0.66

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Largest filed tie

39.00%

of NKTR revenue · UCB

customerNKTR 10-K

Supply chain

Largest filed tie

13F top-10 QoQ

+49.51%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

240 managers

Top fund weight

0.08%

NKTR weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Nektar Therapeutics (NKTR) reports on Nov 12 after close (confirmed date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 13 '26confirmed±5.8%▼−3.82%×0.66

quarterimplied−10%0+10%realized×

Q2 FY26±5.8%▼−3.82%×0.66

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 6 expiries · Oct 28 close

0.42OI · 6 expiries · Oct 28 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

5,1460%Nov 2017d12,1750%

170%Dec 1845d1.21140%1.21

3,4260%Jan 1573d0.388,9060%0.38

500%Feb 19108d0.105120%0.10

170−1%Mar 19136d0.111,5340%0.11

1940%Apr 16164d0.286920%0.28

ExpiryPutsCallsP/C

Nov 2017d5,1460%12,1750%0.42

Dec 1845d170%140%1.21

Jan 1573d3,4260%8,9060%0.38

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±11.8%

Funds 3

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−400.97%as filednet margin · revenue −6.72% QoQ · −9.34% YoY

Revenue$10M−6.72%

Gross profit$10M100.00%−6.72%

Operating income−$42M−417.94%−8.42%

Pre-tax income−$40M+6.47%

Net income−$41M−400.97%+9.54%

Cost of revenue$0—

Operating expenses$52M+5.12%

Tax$2,000−96.88%

Other income$2M+150.55%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

NFP ×1.49· ±6.3% vs ±4.2% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±6.3%3 of 10×1.49

FOMCrate decision±3.4%9 of 24×0.81

PCEpersonal income & outlays±3.2%8 of 19×0.76

CPROFcorporate profits±3.1%6 of 12×0.73

GDPgross domestic product±2.9%11 of 19×0.70

PPIproducer prices±2.8%5 of 10×0.68

CPIconsumer prices±1.6%4 of 10×0.39

Bar = avg |move| to ±7% · tick = ±4.2% avg day · ×base = |move| ÷ ±4.2% · min 6 releases

Earnings history

EPS -1.23 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-1.23	—
Q1 FY26	—	-1.82	—
Q3 FY25	—	-1.87	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod